Значение20202021202220232024TTMДенежный поток от инвестиционной деятельности-7.26 M11.78 M9.7 M10.58 M8.03 M5.3 MДенежный поток от финансовой деятельности61.4 M7.5 M8.02 M8.84 M9.53 M—Свободный денежный поток-31.28 M-36.78 M-23.12 M-18.34 M-19.83 M-22.01 M
Pluri Inc
Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas.